Stockchase Opinions

Joe TerranovaincyteINCYDON'T BUYJun 16, 2025

The momentum has broken badly and has a high PE. But he entered this on a rebound that has momentum. Despite an upgrade today, he doesn't see a green light ahead.

$71.22

Stock price when the opinion was issued

$117.67

As of Jul 24, 2026. Market Open.

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY

Projected 19% earnings growth in 2026, yet trades at under 12x PE 2026. Has a robust drug pipeline.